Clinical Trials and Research Studies

At NYU Langone Health, our doctors and researchers perform clinical trials and research studies with the aim of translating findings into new, more effective treatments.

Recently Added/Updated Trials

  • A Phase I Study of Talimogene Laherparepvec and Panitumumab in Patients with Locally Advanced Squamous Cell Carcinoma of the Skin (SCCS)

    The purpose of the study is to evaluate the side effects and how well talimogene laherparepvec and panitumumab work in treating patients with squamous cell ...

    View Details

  • A PROSPECTIVE SINGLE-SUBJECT SINGLE-BLINDED SINGLE-CENTER STUDY OF THE EFFECTS OF KELOID TREATMENT WITH LASER ASSISTED 5-FLUOROURACIL VERSUS LASER ASSISTED CORTICOSTEROID

    The purpose of this research study is to investigate how well treating keloids (raised scar) with laser and a medication called 5-fluouracil compares to treating ...

    View Details

  • A Phase III Randomized Placebo-Controlled Study of Pembrolizumab (MK-3475 NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA Stage IVB or Recurrent Endometrial Cancer

    The purpose of the study is to determine if we can lower the chance of your endometrial cancer growing or spreading by adding a new ...

    View Details

  • HOPE Consortium Trial to Reduce Pain and Opioid Use in Hemodialysis

    The primary objective is to evaluate the effectiveness of pain coping skills training compared with usual care for reducing pain interference (primary outcome), and for ...

    View Details

  • Post-Viral Autoantibodies in Patients with Cognitive Dysfunction and/or Postural Orthostatic Tachycardia Syndrome (POTS).

    The two study visits will be at the NYU School of Medicine or the first visit could be performed remotely. These visits will last about ...

    View Details

  • Positive Minds Strong Bodies Implementation

    The purpose of this study is to develop and test the implementation of a program to help older adults lead happier and healthier lives by ...

    View Details

  • A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2)

    This is a research study to evaluate the safety and effectiveness of the study drug donanemab to see if it will help slow the mental ...

    View Details

  • A Phase Ib/II Multicenter Open-label Modular Dose-Finding and Dose Expansion Study to Explore the Safety Tolerability and Anti-tumor Activity of Trastuzumab Deruxtecan (DS-8201a T-DXd) in Combination with other Anti-cancer Agents in Patients with Metastatic HER2-positive Breast Cancer (DESTINY-Breast07)

    The purpose of the study is to determine if study drug Trastuzumab Deruxtecan (T-DXd) can be given safely in combination with other cancer treatments to ...

    View Details